Allergan plc
http://www.allergan.com
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Allergan plc
Finance Watch: A SPACtacular Week For Biopharma Deals And Dollars
Public Company Edition: Four health care special purpose acquisition vehicles went public and two others announced mergers, but only one biopharma firm priced an IPO during the week of 19-23 October. Replimune’s $250m offering led recent FOPOs.
Finance Watch: Have Investors Reached IPO Fatigue?
Public Company Edition: Codiak, Kiromic, Aligos and Opthea have fallen below their initial public offering values, while Tarsus and Praxis are trading higher. Also, 5AM, MPM and Cormorant took biotech SPACs public and Evotec led recent non-IPO financings with a €250m private placement.
Revance Builds Therapeutics Credibility For DaxibotulinumtoxinA Ahead Of Aesthetics Launch
The long-acting neuromodulator improved symptoms of cervical dystonia in a Phase III trial with longer duration of efficacy versus older products; a launch for aesthetics is expected soon.
BMS Sees Zeposia As Safer Oral Option In Ulcerative Colitis
Bristol Myers Squibb reported detailed results from the Phase III TRUE NORTH study that show durable remissions in a patient population that switches therapies due to loss of response.
Company Information
- Industry
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
- OTC, Consumer
- Specialty Pharmaceuticals
-
Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
- Other Names / Subsidiaries
-
- Actavis, Inc.
- Actavis plc
- Akarna Therapeutics Ltd.
- Allergan, Inc.
- Anterios, Inc.
- Arrow Group (Subsidiaries: Arrow Generics (U.K), Cobalt Group (U.S.))
- AqueSys, Inc.
- Bonti, Inc.
- Chase Pharmaceuticals Corporation, Inc.
- Durata Therapeutics
- Elastagen Pty Ltd
- EndoArt SA
- Envy Medical, Inc.
- Forest Laboratories [Aptalis Pharmaceutical Technologies
- (Axcan Pharma, Inc.
- Eurand N.V.
- Mpex Pharmaceuticals, Inc.)
- Cerexa, Inc.
- Clinical Data, Inc.]
- Furiex Pharmaceuticals, Inc. (PPD, Inc.)
- Kythera Biopharmaceuticals, Inc.
- MAP Pharmaceuticals
- Motus Therapeutics, Inc. (Rhythm Health, Inc.)
- Naurex, Inc.
- Oculeve
- Regado Biosciences, Inc.
- RetroSense Therapeutics, LLC
- Silom Medical Company
- Uteron Pharma SA
- Warner Chilcott PLC (Galen Holdings PLC)
- Watson Pharmaceuticals, Inc.
- Tobira Therapeutics, Inc.
- Topokine Therapeutics
- Vitae Pharmaceuticals, Inc.
- ForSight VISION5, Inc.
- LifeCell Corporation
- ZELTIQ Aesthetics, Inc.
- Zonagen, Inc.
- Repros Therapeutics, Inc.